Read the Journal “suPAR News” No. 2, 2019 – with lots of interesting articles and interviews from around Europe!
Read the Journal here:
Among others, read the articles
- “suPAR in Chronic and Acute Heart Failure” by MD, PhD Anne Marie Dupuy, University Hospital of Montpellier, France – which is the first hospital where suPAR is in clinical routine on cobas c502 from Roche Diagnostics.
- “suPAR predicts complications in type 1 diabetes”, with interviews with Prof. Peter Rossing and Dr. Viktor Rotbain Curovic, Steno Diabetes Center in Denmark, about suPAR´s predictive qulities for complications in type 1 diabetes.
- “suPAR may guide antibiotic treatment of patients suspected of developing sepsis” by Prof. Evangelos J. Giamarellos-Bourboulis, MD, PhD from the Attikon University Hospital in Greece, where he is heading a study about suPAR in sepsis patients.
- “suPAR measured before and after major non-cardiac surgery may predict the risk of future complications and mortality” by Asst. Prof. Athanasios Chalkias, University Hospital of Larisa, Greece, about his prospective , single-center observational study, aiming to investigate if suPAR measured pre-operatively and immediately after surgery, can predict the risk of future complications and post-operative mortality following major non-cardiac surgery.
Read these articles and many more in the second issue of suPAR News here:
suPAR News No. 2, 2019